Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registryTransformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivoHuman platelet antigen 1 (HPA 1) genotyping with 5' nuclease assay and sequence-specific primers reveals a single nucleotide deletion in intron 2 of the HPA 1a allele of platelet glycoprotein IIIa.[Three special cases of pregnancy outcome to reflect about].Quantification of human platelet antigen-1a antibodies with the monoclonal antibody immobilization of platelet antigens procedure.Maternal human platelet antigen-1a antibody level correlates with the platelet count in the newborns: a retrospective study.A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia.A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn.Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health care programme?Direct comparison between two quantitative assays in the measurement of maternal anti-HPA-1a antibody in neonatal alloimmune thrombocytopenia (NAIT).T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4+ T cells.Neonatal alloimmune thrombocytopenia in Norway: poor detection rate with nonscreening versus a general screening programme.Is it time to implement HPA-1 screening in pregnancy?Neonatal alloimmune thrombocytopenia is not what it was: a lesson learned from a large prospective screening and intervention program.Quantitative MAIPA: Comparison of different MAIPA protocols.Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention.The cellular immunobiology associated with fetal and neonatal alloimmune thrombocytopenia.Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys.The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes.Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.Foetal/neonatal alloimmune thrombocytopenia in Egypt; human platelet antigen genotype frequencies and antibody detection and follow-up in pregnancies.A newborn with petechiae.True risk of fetal/neonatal alloimmune thrombocytopenia in subsequent pregnancies: a prospective observational follow-up study.Characterization of a human platelet antigen-1a-specific monoclonal antibody derived from a B cell from a woman alloimmunized in pregnancy.A multicenter validation of recombinant β3 integrin-coupled beads to detect human platelet antigen-1 alloantibodies in 498 cases of fetomaternal alloimmune thrombocytopenia.Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune ThrombocytopeniaT cell responses to human platelet antigen-1a involve a unique form of indirect allorecognition.Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model.Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphomaThe proteoglycan repertoire of lymphoid cellsPrevalence of hepatitis B & hepatitis C virus infections in potential blood donors in rural Vietnam.Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patientsSerum amyloid A (SAA)--the precursor of protein AA in secondary amyloidosis.Minimal residual disease detection in breast cancer: improved sensitivity using cytokeratin 19 and epidermal growth factor receptor RT-PCR.Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational studyIncreased risk of transmission of hepatitis C in open heart surgery compared with vascular and pulmonary surgery.In HPA 1a-immunized women the decrease in anti-HPA 1a antibody level during pregnancy is not associated with anti-idiotypic antibodies.Hepatitis B virus-infected peripheral blood progenitor cell harvests in liquid nitrogen freezer containing non-infectious products.Screening test accuracy among potential blood donors of HBsAg, anti-HBc and anti-HCV to detect hepatitis B and C virus infection in rural Cambodia and Vietnam.
P50
Q28287717-C16A8075-EE70-4EA1-A075-7C774D21C190Q28307114-F2B5531A-9ABD-49E2-896C-C0395E74F6F2Q33342125-9B0A39F3-AE3D-486C-B482-08ECDF96B0A0Q33363057-207D005D-FBAB-49D6-90F1-75CC31F32943Q33367644-44636E61-EF60-41D2-BDD2-FB8EDF947775Q33373779-7D8400F7-23EA-42C2-B1EA-FCFD0332F2FBQ33374889-A00E2D32-5A7B-4FD3-A92D-F4E31152ACD4Q33379427-BA79A772-0DDB-4B84-8DF9-9D91A4FBF6F5Q33379717-2691D55E-0B76-422A-8372-1CF8E421ADABQ33381729-3D4C6B31-C342-43AA-AD0E-3CCB6390112EQ33382739-2BE1A731-EC0E-4653-9CC2-AA7BCD54C814Q33383495-CEFF7497-2917-461F-8041-D1AB66E31CDAQ33386108-4DCC738F-2479-4D67-B1E7-29EAC74D87B3Q33387018-0E839F3D-7136-49FA-9AC0-D39713253454Q33391112-C461081D-569F-40B5-8C3A-A2C99426F5DBQ33392862-8BA1648A-55B9-4CF1-8B68-4057060A8F5CQ33395951-4E924A12-7C6C-4AAD-9BDB-A8FA89D9BE41Q33397036-DE96DFC6-83E8-45A3-9BD1-C3358755B34DQ33398407-E382E15B-E7E1-4281-938D-24D78157444EQ33399223-41D35FF2-28AA-42A3-AF50-B8EF1C72C13CQ33401461-63A7D594-49C8-4DE7-ACC8-922F392EA339Q33407081-69292851-6B05-48C0-9FC3-7381D7FF7211Q33420994-D48296BF-A080-4929-B428-23007529750FQ33422790-B83F3C40-F73E-4FED-BA68-BB0D8FC60E74Q33424394-61E9C3AE-2178-4855-B1C9-C16874362FA4Q33435351-FC46AD8C-4523-422F-9737-7DD606AA2E7DQ33435753-7FB47207-C382-4EA0-903F-545C3757CEE1Q33441187-59FE191A-2432-40B3-A3A6-B54E56B1DDFAQ33441520-7447CAD6-8ED0-4571-808F-CE07322EF535Q34448586-B3E6A536-1E4B-4F2A-ABCB-5A2185F2F549Q36208202-D8585E93-CE66-47F2-830D-8432FC0E6196Q36289650-AC327EAE-9C93-4FC5-9455-B73ADDB14B87Q37156943-7EF38729-8D4E-45D9-8344-76B72E165ADFQ39608748-E390E6E0-5B7A-488C-B927-4967656BD179Q40580441-0632D36A-83C4-497D-94BD-978AF621566DQ41512544-B4501970-C656-4E3B-9249-2109E3B39BBAQ42679506-852320BF-742F-4C3B-BF13-505859F48F2FQ43171557-EA7E3736-589B-4E46-BDFD-7C000E144F89Q44046180-AA1601AC-A788-4DDB-8802-5FE754C434F0Q45371301-E01E922D-519F-4B47-B6D4-F0CCF9A75EC4
P50
description
Noors rector magnificus
@nl
name
Anne Husebekk
@ast
Anne Husebekk
@ca
Anne Husebekk
@en
Anne Husebekk
@es
Anne Husebekk
@fi
Anne Husebekk
@fr
Anne Husebekk
@ga
Anne Husebekk
@nb
Anne Husebekk
@nl
Anne Husebekk
@nn
type
label
Anne Husebekk
@ast
Anne Husebekk
@ca
Anne Husebekk
@en
Anne Husebekk
@es
Anne Husebekk
@fi
Anne Husebekk
@fr
Anne Husebekk
@ga
Anne Husebekk
@nb
Anne Husebekk
@nl
Anne Husebekk
@nn
altLabel
A Husebekk
@en
A. Husebekk
@en
Husebekk A
@en
Husebekk A.
@en
Husebekk
@en
prefLabel
Anne Husebekk
@ast
Anne Husebekk
@ca
Anne Husebekk
@en
Anne Husebekk
@es
Anne Husebekk
@fi
Anne Husebekk
@fr
Anne Husebekk
@ga
Anne Husebekk
@nb
Anne Husebekk
@nl
Anne Husebekk
@nn
P1015
P244
P1015
P21
P213
0000 0001 2318 1340
P214
16147121658126390702
P2287
P244
n2011048712
P27
P31
P569
1955-12-15T00:00:00Z
P734
P735
P7859
lccn-n2011048712